[
  {
    "title": "What's in Store for Thermo Fisher (TMO) in Q1 Earnings?",
    "published": 1713200280,
    "posting_price": 91.34999847,
    "close_price": 89.19999695,
    "percent_change": -2.35358682
  },
  {
    "title": "Edwards Lifesciences price target raised by $6 at RBC Capital, here's why",
    "published": 1713164940,
    "posting_price": 91.34999847,
    "close_price": 89.19999695,
    "percent_change": -2.35358682
  },
  {
    "title": "Wedgewood Partners Q1 2024 Client Letter",
    "published": 1712999400,
    "posting_price": 91.34999847,
    "close_price": 89.19999695,
    "percent_change": -2.35358682
  },
  {
    "title": "What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?",
    "published": 1712929860,
    "posting_price": 90.77999878,
    "close_price": 90.27999878,
    "percent_change": -0.55078212
  },
  {
    "title": "How Is The Market Feeling About Edwards Lifesciences?",
    "published": 1712918940,
    "posting_price": 90.77999878,
    "close_price": 90.27999878,
    "percent_change": -0.55078212
  },
  {
    "title": "Abbott\u2019s Nadim Geloo on Triclip\u2019s US launch, Edwards competition",
    "published": 1712911020,
    "posting_price": 90.77999878,
    "close_price": 90.27999878,
    "percent_change": -0.55078212
  },
  {
    "title": "$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today",
    "published": 1712894760,
    "posting_price": 90.77999878,
    "close_price": 90.27999878,
    "percent_change": -0.55078212
  },
  {
    "title": "What Analysts Are Saying About Edwards Lifesciences Stock",
    "published": 1712837160,
    "posting_price": 92.83000183,
    "close_price": 91.41000366,
    "percent_change": -1.5296759
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)",
    "published": 1712818200,
    "posting_price": 92.83000183,
    "close_price": 91.41000366,
    "percent_change": -1.5296759
  },
  {
    "title": "Edwards Lifesciences price target raised by $10 at Mizuho, here's why",
    "published": 1712815260,
    "posting_price": 92.83000183,
    "close_price": 91.41000366,
    "percent_change": -1.5296759
  },
  {
    "title": "Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q1 Earnings?",
    "published": 1712767500,
    "posting_price": 91.73000336,
    "close_price": 91.51000214,
    "percent_change": -0.23983562
  },
  {
    "title": "Revising Edwards Lifesciences Price Target Post-Medtronic\u2019s SMART Study: A Hold Rating Amidst Competitive Pressures",
    "published": 1712711940,
    "posting_price": 91.73000336,
    "close_price": 91.51000214,
    "percent_change": -0.23983562
  },
  {
    "title": "Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It",
    "published": 1712561352,
    "posting_price": 92.61000061,
    "close_price": 92.33999634,
    "percent_change": -0.2915498
  },
  {
    "title": "SMART data a 'modest win' for Medtronic, says Jefferies",
    "published": 1712560800,
    "posting_price": 92.61000061,
    "close_price": 92.33999634,
    "percent_change": -0.2915498
  },
  {
    "title": "Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It",
    "published": 1712521800,
    "posting_price": 92.61000061,
    "close_price": 92.33999634,
    "percent_change": -0.2915498
  },
  {
    "title": "Evercore ISI Remains a Hold on Edwards Lifesciences (EW)",
    "published": 1712229420,
    "posting_price": 93.68000031,
    "close_price": 91.19999695,
    "percent_change": -2.64731357
  },
  {
    "title": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors",
    "published": 1712202960,
    "posting_price": 93.68000031,
    "close_price": 91.19999695,
    "percent_change": -2.64731357
  },
  {
    "title": "Tenet Healthcare (THC) Soars 76% in a Year: What Lies Ahead?",
    "published": 1712162700,
    "posting_price": 93.94999695,
    "close_price": 93.01999664,
    "percent_change": -0.9898886
  },
  {
    "title": "Are Robust Financials Driving The Recent Rally In Edwards Lifesciences Corporation's (NYSE:EW) Stock?",
    "published": 1712142029,
    "posting_price": 93.94999695,
    "close_price": 93.01999664,
    "percent_change": -0.9898886
  },
  {
    "title": "Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. \u00a7 271(e)(1)",
    "published": 1712139131,
    "posting_price": 93.94999695,
    "close_price": 93.01999664,
    "percent_change": -0.9898886
  },
  {
    "title": "Edwards Lifesciences price target raised by $8 at Citi, here's why",
    "published": 1712119920,
    "posting_price": 93.94999695,
    "close_price": 93.01999664,
    "percent_change": -0.9898886
  },
  {
    "title": "$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today",
    "published": 1712061360,
    "posting_price": 93.44999695,
    "close_price": 94.30999756,
    "percent_change": 0.92027891
  },
  {
    "title": "Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript",
    "published": 1714486854,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "published": 1714482009,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "East West Petroleum Nears New Zealand Asset Sale Completion",
    "published": 1714477080,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Bristol-Myers Squibb (BMY) and Laboratory (LH)",
    "published": 1714443660,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "Hold Rating Justified for Edwards Lifesciences Amid TAVR Segment Uncertainties",
    "published": 1714442160,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "Maintaining Buy Rating on Edwards Lifesciences Amid Mixed TAVR Performance and Strong TMTT Growth",
    "published": 1714441800,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)",
    "published": 1714439580,
    "posting_price": 85.34999847,
    "close_price": 84.66999817,
    "percent_change": -0.79671976
  },
  {
    "title": "Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends",
    "published": 1714407480,
    "posting_price": 86.43000031,
    "close_price": 85.94999695,
    "percent_change": -0.55536661
  },
  {
    "title": "What's in Store for Cardinal Health (CAH) in Q3 Earnings?",
    "published": 1714406820,
    "posting_price": 86.43000031,
    "close_price": 85.94999695,
    "percent_change": -0.55536661
  },
  {
    "title": "Truist Financial Reaffirms Their Buy Rating on Edwards Lifesciences (EW)",
    "published": 1714373580,
    "posting_price": 86.43000031,
    "close_price": 85.94999695,
    "percent_change": -0.55536661
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: AbbVie (ABBV), Wave Life Sciences (WVE)",
    "published": 1714373580,
    "posting_price": 86.43000031,
    "close_price": 85.94999695,
    "percent_change": -0.55536661
  },
  {
    "title": "Edwards Lifesciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags",
    "published": 1714222007,
    "posting_price": 86.43000031,
    "close_price": 85.94999695,
    "percent_change": -0.55536661
  },
  {
    "title": "This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss",
    "published": 1714162183,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings",
    "published": 1714151520,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up",
    "published": 1714144140,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Q1 2024 Edwards Lifesciences Corp Earnings Call",
    "published": 1714142319,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today",
    "published": 1714134840,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards gets Q1 boost as Pascal valve repair sales ramp up",
    "published": 1714134480,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)",
    "published": 1714130460,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences Corp (EW) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...",
    "published": 1714117240,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Strong Q1 Performance and Positive Market Trends Reinforce Buy Rating for Edwards Lifesciences",
    "published": 1714115820,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Piper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW)",
    "published": 1714114380,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences (EW) Receives a Hold from Stifel Nicolaus",
    "published": 1714114080,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences price target lowered by $1 at Canaccord, here's why",
    "published": 1714114020,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences price target raised by $3 at UBS, here's why",
    "published": 1714110840,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Edwards Lifesciences (EW) Receives a Buy from RBC Capital",
    "published": 1714109820,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Buy Rating Justified: Edwards Lifesciences Exceeds Q1 Expectations with Strong Sales and Market Growth Prospects",
    "published": 1714106820,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Barclays Reaffirms Their Buy Rating on Edwards Lifesciences (EW)",
    "published": 1714103280,
    "posting_price": 87.0,
    "close_price": 86.43000031,
    "percent_change": -0.65517206
  },
  {
    "title": "Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics",
    "published": 1714082409,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates",
    "published": 1714081938,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates",
    "published": 1714080606,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript",
    "published": 1714079947,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff",
    "published": 1714079083,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences Reports First Quarter Results",
    "published": 1714076100,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences: Q1 Earnings Snapshot",
    "published": 1714062491,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024",
    "published": 1714031700,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences backs FY24 EPS view $2.70-$2.80, consensus $2.75",
    "published": 1714015440,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences sees Q2 adjusted EPS 67c-71c, consensus 70c",
    "published": 1714015380,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences reports Q1 adjusted EPS 66c, consensus 64c",
    "published": 1714015380,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M",
    "published": 1714015200,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?",
    "published": 1714012500,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Edwards Lifesciences options imply 4.8% move in share price post-earnings",
    "published": 1714011900,
    "posting_price": 88.0,
    "close_price": 88.01000214,
    "percent_change": 0.01136607
  },
  {
    "title": "Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?",
    "published": 1713981360,
    "posting_price": 87.87999725,
    "close_price": 88.61000061,
    "percent_change": 0.83068205
  },
  {
    "title": "Rising Demand Likely to Aid GE HealthCare's (GEHC) Q1 Earnings",
    "published": 1713972840,
    "posting_price": 87.87999725,
    "close_price": 88.61000061,
    "percent_change": 0.83068205
  },
  {
    "title": "Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings",
    "published": 1713954300,
    "posting_price": 87.87999725,
    "close_price": 88.61000061,
    "percent_change": 0.83068205
  },
  {
    "title": "June 2025 Options Now Available For Edwards Lifesciences Corp (EW)",
    "published": 1713953040,
    "posting_price": 87.87999725,
    "close_price": 88.61000061,
    "percent_change": 0.83068205
  },
  {
    "title": "Edwards Lifesciences Q1 2024 Earnings Preview",
    "published": 1713932700,
    "posting_price": 87.87999725,
    "close_price": 88.61000061,
    "percent_change": 0.83068205
  },
  {
    "title": "Edwards Lifesciences Corporation: The story continues",
    "published": 1713871533,
    "posting_price": 87.40000153,
    "close_price": 87.75,
    "percent_change": 0.40045591
  },
  {
    "title": "Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?",
    "published": 1713793440,
    "posting_price": 86.54000092,
    "close_price": 86.95999908,
    "percent_change": 0.48532257
  },
  {
    "title": "Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics",
    "published": 1713791761,
    "posting_price": 86.54000092,
    "close_price": 86.95999908,
    "percent_change": 0.48532257
  },
  {
    "title": "A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)",
    "published": 1713700812,
    "posting_price": 86.54000092,
    "close_price": 86.95999908,
    "percent_change": 0.48532257
  },
  {
    "title": "Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?",
    "published": 1713549600,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth",
    "published": 1713540600,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "David Rolfe's Wedgewood Partners 1st-Quarter Letter: 'The Magnificent Roaring '20s'",
    "published": 1713527340,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings",
    "published": 1713527160,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "Will High Medical Care Ratios Hurt Molina's (MOH) Q1 Earnings?",
    "published": 1713526080,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "Spin offs, sales and tuck-ins top medtech deal priorities: Moody\u2019s",
    "published": 1713503305,
    "posting_price": 87.19999695,
    "close_price": 85.94000244,
    "percent_change": -1.44494788
  },
  {
    "title": "Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?",
    "published": 1713453240,
    "posting_price": 87.34999847,
    "close_price": 86.44999695,
    "percent_change": -1.03033948
  },
  {
    "title": "Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?",
    "published": 1713448980,
    "posting_price": 87.34999847,
    "close_price": 86.44999695,
    "percent_change": -1.03033948
  },
  {
    "title": "Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "published": 1713448911,
    "posting_price": 87.34999847,
    "close_price": 86.44999695,
    "percent_change": -1.03033948
  },
  {
    "title": "Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024",
    "published": 1713438600,
    "posting_price": 87.34999847,
    "close_price": 86.44999695,
    "percent_change": -1.03033948
  },
  {
    "title": "Behind the Scenes of Edwards Lifesciences's Latest Options Trends",
    "published": 1713411240,
    "posting_price": 87.34999847,
    "close_price": 86.44999695,
    "percent_change": -1.03033948
  },
  {
    "title": "Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?",
    "published": 1713366060,
    "posting_price": 89.88999939,
    "close_price": 87.23999786,
    "percent_change": -2.94804934
  },
  {
    "title": "Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?",
    "published": 1713366060,
    "posting_price": 89.88999939,
    "close_price": 87.23999786,
    "percent_change": -2.94804934
  },
  {
    "title": "Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?",
    "published": 1713290640,
    "posting_price": 89.08999634,
    "close_price": 90.05000305,
    "percent_change": 1.07756959
  },
  {
    "title": "UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View",
    "published": 1713288300,
    "posting_price": 89.08999634,
    "close_price": 90.05000305,
    "percent_change": 1.07756959
  },
  {
    "title": "Align Technology (ALGN) to Post Q1 Earnings: What's in Store?",
    "published": 1713282660,
    "posting_price": 89.08999634,
    "close_price": 90.05000305,
    "percent_change": 1.07756959
  },
  {
    "title": "ITGR vs. EW: Which Stock Should Value Investors Buy Now?",
    "published": 1713282005,
    "posting_price": 89.08999634,
    "close_price": 90.05000305,
    "percent_change": 1.07756959
  },
  {
    "title": "What's in Store for Boston Scientific (BSX) in Q1 Earnings?",
    "published": 1713278640,
    "posting_price": 89.08999634,
    "close_price": 90.05000305,
    "percent_change": 1.07756959
  }
]